Case number 2016-1284
Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | HELSINN HEALTHCARE S.A. v. TEVA PHARMACEUTICALS USA, INC. [OPINION] [precedential] (0) |
| Apr 23, 2021 | 0 | HELSINN HEALTHCARE S.A. v. TEVA PHARMACEUTICALS USA, INC. [ERRATA] [precedential] (0) |
| Oct 19, 2018 | 219 | Record transmitted to the Supreme Court on 10/19/2018. [JCP] [Entered: 10/19/2018 03:43 PM] (36) |
| Oct 15, 2018 | 218 | Letter from the Supreme Court of the United States requesting the entire record and briefs. [558087] [JCP] [Entered: 10/17/2018 01:15 PM] (2) |
| Jun 25, 2018 | 217 | The petition for writ of certiorari, [17-1229], filed on 02/28/2018, was Granted on 06/25/2018. [531741] [JAB] [Entered: 06/25/2018 03:11 PM] (1) |
| Mar 5, 2018 | 216 | Petition for writ of Certiorari filed on 02/28/2018, and placed on the docket 03/02/2018, in the Supreme Court of the United States. Supreme Court #: 17-1229, Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., et al. [502582] [JAB] [Entered: 03/05/2018 02:54 PM] (1) |
| Jan 29, 2018 | 215 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by Clerk of Court. [493476] [16-1284, 16-1787] [SJ] [Entered: 01/29/2018 04:32 PM] (1) |
| Jan 26, 2018 | 214 | Notice from Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. Concerning Chief Justices Denial of Application to Stay This Courts Mandate. Service: 01/26/2018 by email, US mail. [493056] [Steffen Johnson] [Entered: 01/26/2018 12:46 PM] (3) |
| Jan 24, 2018 | 213 | ORDER filed granting motion to mark material as confidential [201] filed by Appellee Helsinn Healthcare S.A. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [492283] [SJ] [Entered: 01/24/2018 11:37 AM] (2) |
| Jan 22, 2018 | 207 | RESPONSE of Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. to the motion to stay mandate [199] filed by Appellee Helsinn Healthcare S.A. in 16-1284. Service: 01/22/2018 by email, US mail. [491347] [Steffen Johnson] [Entered: 01/22/2018 11:53 AM] (28) |
| Jan 22, 2018 | 208 | Sealed or confidential document received [Confidential Opposition to Motion to Stay the Mandate] (corresponding to Doc No. [207]) for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 01/22/2018 by email, US mail. [491355] [Steffen Johnson] [Entered: 01/22/2018 11:57 AM] (0) |
| Jan 22, 2018 | 209 | Notice from Appellee Helsinn Healthcare S.A. Regarding Motion to Stay Mandate Pending Petition for Writ of Certiorari. Service: 01/22/2018 by email, US mail. [491366] [Joseph O'Malley] [Entered: 01/22/2018 12:06 PM] (5) |
| Jan 22, 2018 | 210 | RESPONSE of Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. to the motion to stay mandate [199] filed by Appellee Helsinn Healthcare S.A. in 16-1284. Service: 01/22/2018 by email, US mail. [491404] [Steffen Johnson] [Entered: 01/22/2018 12:42 PM] (62) |
| Jan 22, 2018 | 211 | Sealed or confidential document received [Corrected Confidential Opposition to Motion to Stay the Mandate] (corresponding to Doc No. [210]) for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 01/22/2018 by email, US mail. [491417] [Steffen Johnson] [Entered: 01/22/2018 12:47 PM] (0) |
| Jan 22, 2018 | 212 | ORDER filed denying [199] motion to stay mandate filed by Helsinn Healthcare S.A.. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [491632] [SJ] [Entered: 01/22/2018 04:59 PM] (2) |
| Jan 18, 2018 | 196 | Entry of appearance for Kannon K. Shanmugam as of counsel for Appellee Helsinn Healthcare S.A.. Service: 01/18/2018 by email. [490638] [Kannon Shanmugam] [Entered: 01/18/2018 11:07 AM] (0) |
| Jan 18, 2018 | 197 | Entry of appearance for David M. Krinsky as of counsel for Appellee Helsinn Healthcare S.A.. Service: 01/18/2018 by email. [490640] [David Krinsky] [Entered: 01/18/2018 11:10 AM] (0) |
| Jan 18, 2018 | 198 | Entry of appearance for Amy Mason Saharia as of counsel for Appellee Helsinn Healthcare S.A.. Service: 01/18/2018 by email. [490642] [Amy Saharia] [Entered: 01/18/2018 11:13 AM] (0) |
| Jan 18, 2018 | 199 | MOTION of Appellee Helsinn Healthcare S.A. to stay execution of the mandate until Pending Petition for Writ of Certiorari. [Consent: opposed]. Service: 01/18/2018 by email, US mail. [490654] [Joseph O'Malley] [Entered: 01/18/2018 11:50 AM] (50) |
| Jan 18, 2018 | 200 | Sealed or confidential document received [Appellee Helsinn Healthcare S.A.'s Confidential Motion to Stay Mandate Pending Petition for Writ of Certiorari] (corresponding to Doc No. [199]) for Appellee Helsinn Healthcare S.A.. Service: 01/18/2018 by email, US mail. [490655] [Joseph O'Malley] [Entered: 01/18/2018 11:55 AM] (0) |
| Jan 18, 2018 | 201 | MOTION of Appellee Helsinn Healthcare S.A. to seal document confidential document [200]. Any response is due within 10 days of service [Consent: unopposed]. Service: 01/18/2018 by email, US mail. [490666] [Joseph O'Malley] [Entered: 01/18/2018 12:08 PM] (39) |
| Jan 18, 2018 | 202 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [198] [197] [196] filed by Appellee Helsinn Healthcare S.A. in 16-1284 is without a proper/complete proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [490684] [SJ] [Entered: 01/18/2018 01:04 PM] (0) |
| Jan 18, 2018 | 203 | Corrected Entry of appearance for Kannon K. Shanmugam as of counsel for Appellee Helsinn Healthcare S.A.. Service: 01/18/2018 by email, US mail. [490706] [Kannon Shanmugam] [Entered: 01/18/2018 02:14 PM] (2) |
| Jan 18, 2018 | 204 | Corrected Entry of appearance for David M. Krinsky as of counsel for Appellee Helsinn Healthcare S.A.. Service: 01/18/2018 by email, US mail. [490707] [David Krinsky] [Entered: 01/18/2018 02:17 PM] (2) |
| Jan 18, 2018 | 205 | Corrected Entry of appearance for Amy Mason Saharia as of counsel for Appellee Helsinn Healthcare S.A.. Service: 01/18/2018 by email, US mail. [490708] [Amy Saharia] [Entered: 01/18/2018 02:19 PM] (2) |
| Jan 18, 2018 | 206 | ORDER filed requesting a response to [199] motion to stay mandate. Response/Opposition is due 01/22/2018. By: (Per Curiam). Service as of this date by Clerk of Court. [490731] [SJ] [Entered: 01/18/2018 02:56 PM] (2) |
| Jan 16, 2018 | 195 | ORDER filed denying [136] petition for en banc rehearing filed by Helsinn Healthcare S.A. By: En Banc (Per Curiam). O'Malley, Circuit Judge, concurring in the denial of panel rehearing. Service as of this date by Clerk of Court. [489762] [SJ] [Entered: 01/16/2018 02:01 PM] (15) |
| Aug 28, 2017 | 194 | 18 paper copies of the response [193] received from Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. [457066] [SJ] [Entered: 08/28/2017 01:22 PM] (0) |
| Aug 25, 2017 | 193 | RESPONSE of Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. to the petition for en banc rehearing [136] filed by Appellee Helsinn Healthcare S.A. in 16-1284. Service: 08/25/2017 by email, US mail. [456705] [Julia Johnson] [Entered: 08/25/2017 01:39 PM] (25) |
| Jul 31, 2017 | 192 | ERRATA to the Precedential Opinion Doc No.: [133]. Service as of this date by Clerk of Court. [450284] [16-1284, 16-1787] [JAB] [Entered: 07/31/2017 09:54 AM] (1) |
| Jul 25, 2017 | 191 | ORDER filed granting motion to extend time to file a response to en banc/rehearing petition [189] filed by Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. No further extensions. By: (Per Curiam). Service as of this date by Clerk of Court. [448918] [SJ] [Entered: 07/25/2017 09:42 AM] (2) |
| Jul 21, 2017 | 190 | 18 paper copies of the amicus Brief [177] received from Amicus Curiae AIPLA. [448195] [SJ] [Entered: 07/21/2017 10:50 AM] (0) |
| Jul 20, 2017 | 188 | ORDER filed denying [187] motion to file amicus brief on en banc or rehearing petition filed by Naples Roundtable, Inc. By: (Per Curiam). Service as of this date by Clerk of Court. [448006] [SJ] [Entered: 07/20/2017 04:03 PM] (2) |
| Jul 20, 2017 | 189 | MOTION of Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. to extend the time to file a response to the Petition for Rehearing En Banc until 08/25/2017. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/20/2017 by email, US mail. [448040] [Steffen Johnson] [Entered: 07/20/2017 05:27 PM] (8) |
| Jul 19, 2017 | 176 | ORDER filed granting motions to file amicus brief on en banc or rehearing petition [172] [165] [159] [154] filed by Amici Curiae Pharmaceutical Research and Manufacturers of America, Biotechnology Innovation Organization, AIPLA, and Boston Patent Law Association. By: (Per Curiam). Service as of this date by Clerk of Court. [447613] [SJ] [Entered: 07/19/2017 12:31 PM] (2) |
| Jul 19, 2017 | 177 | AMICUS BRIEF FILED on Petition for AIPLA [156]. Pages: 10. The filer is directed to submit the approriate number of copies within two days, see Fed. Cir. R. 25(c). [447619] [SJ] [Entered: 07/19/2017 01:00 PM] (18) |
| Jul 19, 2017 | 178 | AMICUS BRIEF FILED on Petition for Biotechnology Innovation Organization[160]. Pages: 10. The filer is directed to submit the approriate number of copies within two days, see Fed. Cir. R. 25(c). [447621] [SJ] [Entered: 07/19/2017 01:02 PM] (17) |
| Jul 19, 2017 | 179 | AMICUS BRIEF FILED on Petition for Boston Patent Law Association [166]. Pages: 9. The filer is directed to submit the approriate number of copies within two days, see Fed. Cir. R. 25(c). [447624] [SJ] [Entered: 07/19/2017 01:10 PM] (15) |
| Jul 19, 2017 | 180 | AMICUS BRIEF FILED on Petition for Pharmaceutical Research and Manufacturers of America [173]. Pages: 10. The filer is directed to submit the approriate number of copies within two days, see Fed. Cir. R. 25(c). [447626] [SJ] [Entered: 07/19/2017 01:15 PM] (16) |
| Jul 19, 2017 | 181 | ORDER filed granting motion to withdraw attorneys [153] filed by Amici Curiae Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization. By: (Per Curiam). Service as of this date by Clerk of Court. [447635] [SJ] [Entered: 07/19/2017 01:30 PM] (2) |
| Jul 19, 2017 | 182 | 18 paper copies of the amicus Brief [178] received from Amicus Curiae Biotechnology Innovation Organization. [447642] [SJ] [Entered: 07/19/2017 01:44 PM] (0) |
| Jul 19, 2017 | 183 | 18 paper copies of the amicus Brief [179] received from Amicus Curiae Boston Patent Law Association. [447643] [SJ] [Entered: 07/19/2017 01:44 PM] (0) |
| Jul 19, 2017 | 184 | Certificate of Interest for the Amicus Curiae Boston Patent Law Association. Service: 07/19/2017 by email. [447648] [Ronald Cahill] [Entered: 07/19/2017 01:53 PM] (2) |
| Jul 19, 2017 | 185 | 18 paper copies of the amicus Brief [180] received from Amicus Curiae Pharmaceutical Research and Manufacturers of America. [447682] [SJ] [Entered: 07/19/2017 02:43 PM] (0) |
| Jul 19, 2017 | 186 | Certificate of Interest for the Amicus Curiae Biotechnology Innovation Organization. Service: 07/19/2017 by email. [447705] [Hansjorg Sauer] [Entered: 07/19/2017 03:17 PM] (3) |
| Jul 19, 2017 | 187 | MOTION of Amicus Curiae Naples Roundtable, Inc. for leave to file amicus brief in support of Appellee on petition for en banc rehearing [136]. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/19/2017 by email, US mail. [447735] [Larry Shatzer] [Entered: 07/19/2017 04:05 PM] (5) |
| Jul 17, 2017 | 174 | The court invites a response from Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. to the petition for en banc rehearing filed by Appellee in 16-1284. [446986] [SJ] [Entered: 07/17/2017 01:15 PM] (1) |
| Jul 17, 2017 | 175 | Certificate of Interest for the Amicus Curiae Intellectual Property Owners Association. Service: 07/17/2017 by email, US mail. [447170] [Mark Lauroesch] [Entered: 07/17/2017 06:03 PM] (2) |
| Jul 14, 2017 | 154 | MOTION of Amicus Curiae AIPLA for leave to file amicus brief in support of Plaintiffs-Appellees on petition for en banc rehearing [136]. Any response is due within 10 days of service [Consent: not addressed]. Service: 07/14/2017 by email, US mail. [446563] [Lynn Tyler] [Entered: 07/14/2017 10:47 AM] (6) |
| Jul 14, 2017 | 155 | ORDER filed granting motion to file amicus brief on en banc or rehearing petition [148] filed by Intellectual Property Owners Association. By: (Per Curiam). Service as of this date by Clerk of Court. [446565] [SJ] [Entered: 07/14/2017 10:49 AM] (2) |
| Jul 14, 2017 | 156 | TENDERED from Amicus Curiae AIPLA. Title: AMICUS CURIAE BRIEF. Service: 07/14/2017 by email. [446567] [Lynn Tyler] [Entered: 07/14/2017 10:51 AM] (18) |
| Jul 14, 2017 | 157 | AMICUS BRIEF FILED on Petition for Intellectual Property Owners Association[149]. Pages: 11. The filer is directed to submit the approriate number of copies within two days, see Fed. Cir. R. 25(c). [446568] [SJ] [Entered: 07/14/2017 10:53 AM] (21) |
| Jul 14, 2017 | 158 | 18 paper copies of the amicus Brief [157] received from Amicus Curiae Intellectual Property Owners Association. [446579] [SJ] [Entered: 07/14/2017 11:12 AM] (0) |
| Jul 14, 2017 | 159 | MOTION of Amicus Curiae Biotechnology Innovation Organization for leave to file amicus brief in support of Neither Party on petition for en banc rehearing [136]. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/14/2017 by email, US mail. [446637] [Hansjorg Sauer] [Entered: 07/14/2017 01:54 PM] (6) |
| Jul 14, 2017 | 160 | TENDERED from Amicus Curiae Biotechnology Innovation Organization. Title: AMICUS CURIAE BRIEF. Service: 07/14/2017 by email. [446638] [Hansjorg Sauer] [Entered: 07/14/2017 01:55 PM] (17) |
| Jul 14, 2017 | 161 | Entry of appearance for Hans Sauer as principal counsel for Amicus Curiae Biotechnology Innovation Organization. Service: 07/14/2017 by email, US mail. [446640] [Hansjorg Sauer] [Entered: 07/14/2017 01:56 PM] (2) |
| Jul 14, 2017 | 162 | Entry of appearance for Melissa Brand as of counsel for Amicus Curiae Biotechnology Innovation Organization. Service: 07/14/2017 by email, US mail. [446641] [Hansjorg Sauer] [Entered: 07/14/2017 01:57 PM] (2) |
| Jul 14, 2017 | 163 | Entry of appearance for Brian P. Barrett as of counsel for Amicus Curiae Biotechnology Innovation Organization. Service: 07/14/2017 by email, US mail. [446642] [Hansjorg Sauer] [Entered: 07/14/2017 01:57 PM] (2) |
| Jul 14, 2017 | 164 | TENDERED from Amicus Curiae Naples Roundtable, Inc.. Title: AMICUS CURIAE BRIEF. Service: 07/14/2017 by email. [446647] [Larry Shatzer] [Entered: 07/14/2017 02:19 PM] (0) |
| Jul 14, 2017 | 165 | MOTION of Boston Patent Law Association for leave to file amicus brief in support of Neither Party on petition for en banc rehearing [136]. Any response is due within 10 days of service [Consent: partial consent]. Service: 07/14/2017 by email, US mail. [446651] [Ronald Cahill] [Entered: 07/14/2017 02:51 PM] (6) |
| Jul 14, 2017 | 166 | TENDERED from Boston Patent Law Association Title: AMICUS CURIAE BRIEF. Service: 07/14/2017 by email. [446652] [Ronald Cahill] [Entered: 07/14/2017 02:52 PM] (15) |
| Jul 14, 2017 | 167 | Entry of appearance for Ronald E. Cahill as principal counsel for Boston Patent Law Association. Service: 07/14/2017 by email, US mail. [446653] [Ronald Cahill] [Entered: 07/14/2017 02:53 PM] (2) |
| Jul 14, 2017 | 168 | Entry of appearance for Micah W. Miller as of counsel for Boston Patent Law Association. Service: 07/14/2017 by email, US mail. [446654] [Ronald Cahill] [Entered: 07/14/2017 02:54 PM] (2) |
| Jul 14, 2017 | 169 | Entry of appearance for Scott E. Kamholz as principal counsel for Amicus Curiae Pharmaceutical Research and Manufacturers of America. Service: 07/14/2017 by email, US mail. [446700] [Scott Kamholz] [Entered: 07/14/2017 04:01 PM] (2) |
| Jul 14, 2017 | 170 | Entry of appearance for David E. Korn as of counsel for Amicus Curiae Pharmaceutical Research and Manufacturers of America. Service: 07/14/2017 by email, US mail. [446701] [Scott Kamholz] [Entered: 07/14/2017 04:03 PM] (2) |
| Jul 14, 2017 | 171 | Certificate of Interest for the Amicus Curiae Pharmaceutical Research and Manufacturers of America. Service: 07/14/2017 by email, US mail. [446703] [Scott Kamholz] [Entered: 07/14/2017 04:06 PM] (2) |
| Jul 14, 2017 | 172 | MOTION of Amicus Curiae Pharmaceutical Research and Manufacturers of America for leave to file amicus brief in support of Appellee Helsinn Healthcare S.A. on petition for en banc rehearing [136]. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/14/2017 by email, US mail. [446708] [Scott Kamholz] [Entered: 07/14/2017 04:10 PM] (7) |
| Jul 14, 2017 | 173 | TENDERED from Amicus Curiae Pharmaceutical Research and Manufacturers of America. Title: AMICUS CURIAE BRIEF. Service: 07/14/2017 by email. [446716] [Scott Kamholz] [Entered: 07/14/2017 04:14 PM] (16) |
| Jul 12, 2017 | 152 | 18 paper copies of the amicus Brief [151] received from Amicus Curiae Lamar Smith. [445962] [SJ] [Entered: 07/12/2017 03:10 PM] (0) |
| Jul 12, 2017 | 153 | MOTION of Amici Curiae Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America to withdraw counsel Jamie T. Wisz, Thomas G. Saunders, and Robbie Manhas. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/12/2017 by email. [446029] [Jamie Wisz] [Entered: 07/12/2017 06:50 PM] (4) |
| Jul 11, 2017 | 142 | Entry of appearance for Robert M. Isackson as principal counsel for Intellectual Property Owners Association. Service: 07/11/2017 by email. [445542] [Mark Lauroesch] [Entered: 07/11/2017 11:14 AM] (2) |
| Jul 11, 2017 | 143 | Entry of appearance for Joshua C. Cumby as of counsel for Intellectual Property Owners Association. Service: 07/11/2017 by email. [445545] [Mark Lauroesch] [Entered: 07/11/2017 11:19 AM] (2) |
| Jul 11, 2017 | 144 | Entry of appearance for Mark W. Lauroesch as of counsel for Intellectual Property Owners Association. Service: 07/11/2017 by email. [445548] [Mark Lauroesch] [Entered: 07/11/2017 11:23 AM] (2) |
| Jul 11, 2017 | 145 | Entry of appearance for Steven W. Miller as of counsel for Intellectual Property Owners Association. Service: 07/11/2017 by email. [445550] [Mark Lauroesch] [Entered: 07/11/2017 11:25 AM] (2) |
| Jul 11, 2017 | 146 | Entry of appearance for Todd M. Nosher as of counsel for Intellectual Property Owners Association. Service: 07/11/2017 by email. [445551] [Mark Lauroesch] [Entered: 07/11/2017 11:26 AM] (2) |
| Jul 11, 2017 | 147 | Entry of appearance for Kevin H. Rhodes as of counsel for Intellectual Property Owners Association. Service: 07/11/2017 by email. [445552] [Mark Lauroesch] [Entered: 07/11/2017 11:27 AM] (2) |
| Jul 11, 2017 | 148 | MOTION of Intellectual Property Owners Association for leave to file amicus brief in support of Plaintiff-Appellee on petition for en banc rehearing [136]. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/11/2017 by email. [445564] [Mark Lauroesch] [Entered: 07/11/2017 11:38 AM] (7) |
| Jul 11, 2017 | 149 | TENDERED from Intellectual Property Owners Association Title: AMICUS CURIAE BRIEF. Service: 07/11/2017 by email. [445568] [Mark Lauroesch] [Entered: 07/11/2017 11:40 AM] (21) |
| Jul 11, 2017 | 150 | ORDER filed granting motion to file amicus brief on en banc or rehearing petition [139] filed by Amicus Curiae Lamar Smith. By: (Per Curiam). Service as of this date by Clerk of Court. [445583] [SJ] [Entered: 07/11/2017 11:59 AM] (2) |
| Jul 11, 2017 | 151 | AMICUS BRIEF FILED on Petition for Lamar Smith[137]. Pages: 10. The filer is directed to submit the approriate number of copies within two days, see Fed. Cir. R. 25(c). [445587] [SJ] [Entered: 07/11/2017 12:01 PM] (17) |
| Jul 6, 2017 | 141 | Notice from Amicus Curiae US Withdrawal of Counsel. Service: 07/06/2017 by email, US mail. [444645] [William Havemann] [Entered: 07/06/2017 05:28 PM] (2) |
| Jul 5, 2017 | 140 | 18 paper copies of the petition for en banc rehearing [136] received from Appellee Helsinn Healthcare S.A. [444109] [JAB] [Entered: 07/05/2017 11:02 AM] (0) |
| Jul 3, 2017 | 138 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Brief Docket No. [137], ERROR: Motion may NOT be attached to brief, and does not contain a statement addressing consent. CORRECTION: Counsel should REFILE motion using 'MOTION FILED' event - category 'AMICUS', description 'FILE AMICUS BRIEF ON EN BANC OR REHEARING PETITION'. The document is hereby rejected until resubmitted properly. [443790]--[Edited 07/03/2017 by clerk to add deficiency] [SJ] [Entered: 07/03/2017 09:45 AM] (0) |
| Jul 3, 2017 | 139 | MOTION of Amicus Curiae Lamar Smith for leave to file amicus brief in support of Appellee on petition for en banc rehearing [136]. Any response is due within 10 days of service [Consent: not addressed]. Service: 07/03/2017 by email, US mail. [443948] [Robert Armitage] [Entered: 07/03/2017 03:30 PM] (2) |
| Jun 30, 2017 | 136 | Petition for en banc rehearing filed by Appellee Helsinn Healthcare S.A.. Service: 06/30/2017 by email, US mail. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 07/05/2017 [443615] [Joseph O'Malley] [Entered: 06/30/2017 03:57 PM] (59) |
| Jun 30, 2017 | 137 | TENDERED from Amicus Curiae Lamar Smith. Title: AMICUS CURIAE BRIEF. Service: 06/30/2017 by email. [443705] [Robert Armitage] [Entered: 06/30/2017 08:53 PM] (17) |
| May 17, 2017 | 135 | ORDER filed granting motion to extend time to file petition for rehearing [134] filed by Appellee Helsinn Healthcare S.A. Petition for Rehearing due on or before 06/30/2017. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [432130] [JCA] [Entered: 05/17/2017 10:00 AM] (2) |
| May 15, 2017 | 134 | MOTION of Appellee Helsinn Healthcare S.A. to extend the time to file a Petition for Rehearing En Banc until 06/30/2017 at 11:59 pm. [Consent: unopposed]. Service: 05/15/2017 by email, US mail. [431478] [Joseph O'Malley] [Entered: 05/15/2017 03:41 PM] (12) |
| May 1, 2017 | 133 | OPINION and JUDGMENT filed. The judgment or decision is: Reversed. (Precedential Opinion). (For the Court: Dyk,Circuit Judge; Mayer,Circuit Judge and O'Malley,Circuit Judge). [428102] [16-1284, 16-1787] [JCA] [Entered: 05/01/2017 09:42 AM] (38) |
| Oct 17, 2016 | 132 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellee Helsinn Healthcare S.A.. Service: 10/17/2016 by email, US mail. [374729] [Joseph O'Malley] [Entered: 10/17/2016 11:01 AM] (2) |
| Oct 4, 2016 | 131 | Submitted after ORAL ARGUMENT by Mr. William Ernest Havemann for US, Mr. George C. Lombardi, Esq. for Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. and Mr. Joseph M. O'Malley, Jr. for Helsinn Healthcare S.A.. Panel: Judge: Dyk , Judge: Mayer , Judge: O'Malley. [371295] [JCP] [Entered: 10/04/2016 11:55 AM] (0) |
| Sep 15, 2016 | 128 | Response to oral argument order from the Appellee Helsinn Healthcare S.A.. designating Joseph M. O'Malley, Jr. as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [366761] [Joseph O'Malley] [Entered: 09/15/2016 04:14 PM] (0) |
| Sep 15, 2016 | 129 | Response to oral argument order from the Amicus Curiae US. designating William E. Havemann as arguing attorney. Designated time for argument: 5 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [366770] [William Havemann] [Entered: 09/15/2016 04:27 PM] (0) |
| Sep 15, 2016 | 130 | Response to oral argument order from the Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. designating George C. Lombardi as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [366792] [George Lombardi] [Entered: 09/15/2016 05:49 PM] (0) |
| Sep 1, 2016 | 127 | ORDER filed granting motion to participate in oral argument [126] filed by Amicus Curiae US; granting motion to seek more time for argument [126] filed by Amicus Curiae US. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [363726] [JAB] [Entered: 09/01/2016 02:33 PM] (2) |
| Aug 31, 2016 | 126 | MOTION of Amicus Curiae US to participate in oral argument. Response/Opposition is due 09/15/2016, for additional time at oral argument. Response/Opposition is due 09/15/2016 [Consent: unopposed]. Service: 08/31/2016 by email, US mail. [363518] [William Havemann] [Entered: 08/31/2016 04:07 PM] (4) |
| Aug 19, 2016 | 125 | NOTICE OF CALENDARING. Panel: 1610J. Case scheduled Oct 04, 2016 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 09/15/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [360472] THIS NOTICE APPLIES TO CASE(S): [16-1176, 16-1178, 16-1284, 16-1348] [JAB] [Entered: 08/19/2016 04:03 PM] (0) |
| Jul 14, 2016 | 124 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellee Helsinn Healthcare S.A.. Service: 07/14/2016 by email. [350741] [Joseph O'Malley] [Entered: 07/14/2016 11:15 AM] (2) |
| Jul 13, 2016 | 123 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 07/13/2016 by email, US mail. [350548] [Andrew Nichols] [Entered: 07/13/2016 03:01 PM] (2) |
| Jun 30, 2016 | 122 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [347740] [JCA] [Entered: 06/30/2016 12:57 PM] (0) |
| Jun 14, 2016 | 120 | MOTION of Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. to withdraw counsel Karl Leonard. Response/Opposition is due 06/27/2016 [Consent: not addressed]. Service: 06/14/2016 by email, US mail. [343345] [Andrew Nichols] [Entered: 06/14/2016 12:22 PM] (4) |
| Jun 14, 2016 | 121 | Notice of Rejection to Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc., the following document(s): motion to withdraw attorney [120] is REJECTED for filing. Reason(s): caption, consent, and notice. Service: 06/14/2016 by clerk. [343425] [JCA] [Entered: 06/14/2016 02:44 PM] (1) |
| May 31, 2016 | 118 | Notice from Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (Conflict on August 1, 2016 and requesting argument August 2-5, 2016.). Service: 05/31/2016 by email, US mail. [339719] [Steffen Johnson] [Entered: 05/31/2016 11:38 PM] (2) |
| May 26, 2016 | 119 | 6 paper copies of the Joint Appendix (Vol. I - II) [115] received from Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. [339846] [MJL] [Entered: 06/01/2016 10:42 AM] (0) |
| May 24, 2016 | 116 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice of Conflict with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 05/31/2016. [337795] [MJL] [Entered: 05/24/2016 09:40 AM] (0) |
| May 24, 2016 | 117 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: A decent portion of the Joint Appendix [114] was not text-searchable. CORRECTION: For future filings, please ensure the entire document is text-searchable. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [337797] [MJL] [Entered: 05/24/2016 09:42 AM] (0) |
| May 23, 2016 | 114 | TENDERED from Appellants Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Appellee Helsinn Healthcare S.A.. Title: JOINT APPENDIX. Service: 05/23/2016 by email. [337567] [George Lombardi] [Entered: 05/23/2016 01:47 PM] (624) |
| May 23, 2016 | 115 | APPENDIX FILED for Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. [114]. Number of Pages: 624. Service: 05/23/2016 by email. Pursuant to Fed. Cir. R. 30(a)(5), filer is directed to file six copies of the appendix in paper format. The paper copies should be received by the court on or before 05/31/2016. [337793] [MJL] [Entered: 05/24/2016 09:40 AM] (624) |
| May 20, 2016 | 113 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Appellee Helsinn Healthcare S.A.. Service: 05/20/2016 by email, US mail. [337106] [Jovial Wong] [Entered: 05/20/2016 12:11 PM] (4) |
| May 18, 2016 | 111 | ORDER granting motion to withdraw party [110] filed by Appellee Roche Palo Alto LLC. The revised official caption is reflected in the order. Service: 05/18/2016 by clerk. [336399] [NL] [Entered: 05/18/2016 12:25 PM] (2) |
| May 17, 2016 | 112 | 6 paper copies of the Reply Brief [109] received from Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. [336599] [MJL] [Entered: 05/18/2016 04:05 PM] (0) |
| May 16, 2016 | 110 | MOTION of Appellee Roche Palo Alto LLC to withdraw party, Roche Palo Alto LLC , as a party to this appeal. Response/Opposition is due 05/31/2016 [Consent: unopposed]. Service: 05/16/2016 by email. [335238] [Charles Lizza] [Entered: 05/16/2016 11:32 AM] (4) |
| May 13, 2016 | 108 | TENDERED from Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Title: REPLY BRIEF. Service: 05/13/2016 by email. [335069] [Andrew Nichols] [Entered: 05/13/2016 07:48 PM] (43) |
| May 13, 2016 | 109 | REPLY BRIEF FILED for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. [108]. Number of Pages: 31. Service: 05/13/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/23/2016. Appendix is due 05/23/2016. [335157] [JCA] [Entered: 05/16/2016 09:53 AM] (43) |
| May 6, 2016 | 107 | 6 paper copies of the Amicus Brief [93] received from Amicus Curiae AIPLA. [334219] [JCP] [Entered: 05/11/2016 01:56 PM] (0) |
| May 4, 2016 | 105 | 6 paper copies of the Amicus Brief [90] received from Amicus Curiae US. [332846] [JCP] [Entered: 05/06/2016 11:29 AM] (0) |
| May 4, 2016 | 106 | 6 paper copies of the Amicus Brief [97] received from Amici Curiae Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America. [332848] [JCP] [Entered: 05/06/2016 11:31 AM] (0) |
| May 3, 2016 | 91 | Clerk's Note to the File: The Certificate of Interest for AIPLA is due on 05/17/2016. Although the COI was filed in the amicus brief, it still needs to be filed as an independent filing on the docket sheet. [331601] [JCA] [Entered: 05/03/2016 12:07 PM] (0) |
| May 3, 2016 | 92 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [82] is without a proper/complete proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [331602] [JCA] [Entered: 05/03/2016 12:07 PM] (0) |
| May 3, 2016 | 94 | Corrected Entry of appearance for Mark L. Whitaker as of counsel for Amicus Curiae AIPLA. Service: 05/03/2016 by email, US mail. [331616] [Lynn Tyler] [Entered: 05/03/2016 12:30 PM] (1) |
| May 3, 2016 | 95 | Clerk's Note to the File: The Certificate of Interest for Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization is due on 05/17/2016. Although the COI was filed in the amicus brief, it still needs to be filed as an independent filing on the docket sheet. [331617] [JCA] [Entered: 05/03/2016 12:31 PM] (0) |
| May 3, 2016 | 96 | Certificate of Interest for the Amicus Curiae AIPLA. Service: 05/03/2016 by email, US mail. [331619] [Lynn Tyler] [Entered: 05/03/2016 12:32 PM] (0) |
| May 3, 2016 | 98 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: attorney entry of appearance for Mark L. Whitaker [94], ERROR: Mr. Whitaker is not registered as an electronic filer with the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), every attorney entering into appearance must register for the court's CM/ECF system. [331671] [MJL] [Entered: 05/03/2016 01:42 PM] (0) |
| May 3, 2016 | 99 | NOTICE OF DEFICIENCY: The certificate of interest [96] filed by Amicus Curiae AIPLA in 16-1284 is incomplete and therefore cannot be accepted for filing at this time. Item #4 was left blank. You are being afforded the opportunity to correct the deficiency. Please ensure every question has an answer. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [331675] [MJL] [Entered: 05/03/2016 01:44 PM] (0) |
| May 3, 2016 | 100 | Certificate of Interest for the Amici Curiae Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America. Service: 05/03/2016 by email, US mail. [331677] [Jamie Wisz] [Entered: 05/03/2016 01:47 PM] (2) |
| May 3, 2016 | 101 | Corrected Certificate of Interest for the Amicus Curiae AIPLA. Service: 05/03/2016 by email, US mail. [331737] [Lynn Tyler] [Entered: 05/03/2016 02:33 PM] (1) |
| May 2, 2016 | 77 | Entry of appearance for Scott C. Weidenfeller as of counsel for United States of America. Service: 05/02/2016 by email, US mail. [331082] [Scott Weidenfeller] [Entered: 05/02/2016 12:10 PM] (2) |
| May 2, 2016 | 78 | Entry of appearance for Joseph Matal as of counsel for United States of America. Service: 05/02/2016 by email, US mail. [331088] [Joseph Matal] [Entered: 05/02/2016 12:22 PM] (2) |
| May 2, 2016 | 79 | Entry of appearance for Joseph G. Piccolo as of counsel for United States of America. Service: 05/02/2016 by email, US mail. [331094] [Joseph Piccolo] [Entered: 05/02/2016 12:28 PM] (2) |
| May 2, 2016 | 80 | Entry of appearance for Thomas W. Krause as of counsel for United States of America. Service: 05/02/2016 by email, US mail. [331110] [Thomas Krause] [Entered: 05/02/2016 12:53 PM] (2) |
| May 2, 2016 | 81 | Entry of appearance for Lynn C. Tyler as principal counsel for American Intellectual Property Law Association. Service: 05/02/2016 by email, US mail. [331178] [Lynn Tyler] [Entered: 05/02/2016 02:14 PM] (1) |
| May 2, 2016 | 82 | Entry of appearance for Mark L. Whitaker as of counsel for American Intellectual Property Law Association. Service: 05/02/2016 by email, US mail. [331187] [Lynn Tyler] [Entered: 05/02/2016 02:18 PM] (0) |
| May 2, 2016 | 83 | Entry of appearance for Jamie T. Wisz as principal counsel for Amici Curiae Pharmaceutical Research and Manufacturers of America; Biotechnology Innovation Organization. Service: 05/02/2016 by email. [331288] [Jamie Wisz] [Entered: 05/02/2016 03:35 PM] (2) |
| May 2, 2016 | 84 | Entry of appearance for Thomas G. Saunders as of counsel for Amici Curiae Pharmaceutical Research and Manufacturers of America; Biotechnology Innovation Organization. Service: 05/02/2016 by email. [331292] [Thomas Saunders] [Entered: 05/02/2016 03:37 PM] (2) |
| May 2, 2016 | 85 | TENDERED from American Intellectual Property Law Association Title: AMICUS CURIAE BRIEF. Service: 05/02/2016 by email. [331354] [Lynn Tyler] [Entered: 05/02/2016 04:47 PM] (36) |
| May 2, 2016 | 86 | TENDERED from United States Title: AMICUS CURIAE BRIEF. Service: 05/02/2016 by email. [331402] [William Havemann] [Entered: 05/02/2016 06:39 PM] (33) |
| May 2, 2016 | 87 | Entry of appearance for Mark R. Freeman as of counsel for United States of America. Service: 05/02/2016 by email, US mail. [331408] [Mark Freeman] [Entered: 05/02/2016 07:04 PM] (1) |
| May 2, 2016 | 88 | Entry of appearance for Robbie Manhas as of counsel for Amici Curiae Pharmaceutical Research and Manufacturers of America; Biotechnology Innovation Organization. Service: 05/02/2016 by email. [331426] [Jamie Wisz] [Entered: 05/02/2016 08:26 PM] (2) |
| May 2, 2016 | 89 | TENDERED from Amici Curiae Pharmaceutical Research and Manufacturers of America; Biotechnology Innovation Organization Title: AMICUS CURIAE BRIEF. Service: 05/02/2016 by email. [331427] [Jamie Wisz] [Entered: 05/02/2016 08:32 PM] (35) |
| May 2, 2016 | 90 | AMICUS BRIEF FILED for US [86]. Number of Pages: 25. Service: 05/02/2016 by email. Pursuant to Fed. Cir. R. 29(a), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/09/2016. [331554] [JCA] [Entered: 05/03/2016 11:12 AM] (33) |
| May 2, 2016 | 93 | AMICUS BRIEF FILED for AIPLA [85]. Number of Pages: 26. Service: 05/02/2016 by email. Pursuant to Fed. Cir. R. 29(a), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/09/2016. [331603] [JCA] [Entered: 05/03/2016 12:10 PM] (36) |
| May 2, 2016 | 97 | AMICUS BRIEF FILED for Biotechnology Innovation Organization and Pharmaceutical Research and Manufacturers of America [89]. Number of Pages: 27. Service: 05/02/2016 by email. Pursuant to Fed. Cir. R. 29(a), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/09/2016. [331621] [JCA] [Entered: 05/03/2016 12:33 PM] (35) |
| Apr 29, 2016 | 104 | 6 paper copies of the amicus Brief [74] received from Amicus Curiae The Naples Roundtable, Inc.. [332027] [LAJ] [Entered: 05/04/2016 10:44 AM] (0) |
| Apr 28, 2016 | 103 | 6 paper copies of the Opening Response Brief [64] received from Appellees Helsinn Healthcare S.A. and Roche Palo Alto LLC. [331938] [LAJ] [Entered: 05/04/2016 08:51 AM] (0) |
| Apr 27, 2016 | 65 | Entry of appearance for Andrew S. Baluch as principal counsel for The Naples Roundtable, Inc.. Service: 04/27/2016 by email. [329963] [Paul Strain] [Entered: 04/27/2016 11:04 AM] (0) |
| Apr 27, 2016 | 66 | Entry of appearance for Larry L. Shatzer as of counsel for The Naples Roundtable, Inc.. Service: 04/27/2016 by email. [329965] [Paul Strain] [Entered: 04/27/2016 11:07 AM] (0) |
| Apr 27, 2016 | 67 | TENDERED from The Naples Roundtable, Inc. Title: AMICUS CURIAE BRIEF. Service: 04/27/2016 by email. [329978] [Paul Strain] [Entered: 04/27/2016 11:27 AM] (25) |
| Apr 27, 2016 | 68 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [66] , attorney entry of appearance Document No. [65] is without a proper/complete proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [330009] [JCA] [Entered: 04/27/2016 01:00 PM] (0) |
| Apr 27, 2016 | 69 | Corrected Entry of appearance for Andrew S. Baluch as principal counsel for The Naples Roundtable, Inc.. Service: 04/27/2016 by email. [330020]--[Edited 05/02/2016 by clerk to flatten pdf] [Paul Strain] [Entered: 04/27/2016 01:24 PM] (2) |
| Apr 27, 2016 | 70 | Corrected Entry of appearance for Larry L. Shatzer as of counsel for The Naples Roundtable, Inc. Service: 04/27/2016 by email. [330021]--[Edited by clerk on 04/28/2016 to flatten pdf to remove form fields] [Paul Strain] [Entered: 04/27/2016 01:27 PM] (2) |
| Apr 27, 2016 | 71 | Entry of appearance for William E. Havemann as principal counsel for United States. Service: 04/27/2016 by email, US mail. [330061] [William Havemann] [Entered: 04/27/2016 03:11 PM] (2) |
| Apr 27, 2016 | 72 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [70], attorney entry of appearance Docket No. [69], ERROR: The firm name and contact information listed on your entry of appearance forms do not match what we have in our database. CORRECTION: Update your firm name and contact information with the PACER service center. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [330065] [JCA] [Entered: 04/27/2016 03:15 PM] (0) |
| Apr 27, 2016 | 73 | Clerk's Note to the File: The Naples Roundtable, Inc. should file their certificate of interest as a separate entry on the docket sheet. Although included in the amicus brief it should still be filed as an independent filing. The deadline to file it is 5/11/16. [330067] [JCA] [Entered: 04/27/2016 03:19 PM] (0) |
| Apr 27, 2016 | 74 | AMICUS BRIEF FILED for The Naples Roundtable, Inc. [67]. Number of Pages: 17. Service: 04/27/2016 by email. Pursuant to Fed. Cir. R. 29(a), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/02/2016. [330068] [JCA] [Entered: 04/27/2016 03:20 PM] (25) |
| Apr 27, 2016 | 75 | Clerk's Note to the File: All counsel are reminded that this case (16-1284) was consolidated with (16-1787) on 4/6/16. All further filings of any type should include both case numbers. (Ref: clerk order to consolidate appeals, [53]) [330073] [JCA] [Entered: 04/27/2016 03:26 PM] (0) |
| Apr 27, 2016 | 76 | Certificate of Interest for the Amicus Curiae The Naples Roundtable, Inc.. Service: 04/27/2016 by email. [330091] [Paul Strain] [Entered: 04/27/2016 04:07 PM] (2) |
| Apr 26, 2016 | 63 | This entry was made in error and has been removed from the docket. NOTICE OF REJECTION: The principal brief of Appellees Helsinn Healthcare S.A. and Roche Palo Alto LLC. [329541] [MJL] [Entered: 04/26/2016 09:17 AM] (0) |
| Apr 25, 2016 | 62 | TENDERED from Appellees Helsinn Healthcare S.A. and Roche Palo Alto LLC. Title: RESPONSE BRIEF. Service: 04/25/2016 by email. [329418] This brief has been rejected. See Doc. No. [63]. [Joseph O'Malley] [Entered: 04/25/2016 04:11 PM] (75) |
| Apr 25, 2016 | 64 | BRIEF FILED for Appellees Helsinn Healthcare S.A. and Roche Palo Alto LLC [62]. Number of Pages: 60. Service: 04/25/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/02/2016. Appellants' reply brief due 5/13/2016. [329553] [MJL] [Entered: 04/26/2016 09:37 AM] (75) |
| Apr 25, 2016 | 102 | 6 paper copies of the Amicus Brief [59] received from Amicus Curiae Lamar Smith. [331836] [JCP] [Entered: 05/03/2016 04:21 PM] (0) |
| Apr 22, 2016 | 60 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [58] is submitted using the incorrect event and therefore cannot be accepted for filing at this time. This is a certificate of interest, however you used the entry of appearance event to file it. Please refile your certificate of interest using the correct event. The due date for the document is 5/6/16. You are being afforded the opportunity to correct the deficiency. [328740] [JCA] [Entered: 04/22/2016 10:11 AM] (0) |
| Apr 22, 2016 | 61 | Corrected Certificate of Interest for the Amicus Curiae Lamar Smith. Service: 04/22/2016 by email, US mail. [328836] [Robert Armitage] [Entered: 04/22/2016 12:01 PM] (2) |
| Apr 21, 2016 | 56 | TENDERED from Congressman Lamar Smith Title: AMICUS CURIAE BRIEF. Service: 04/21/2016 by email. [328549] [Robert Armitage] [Entered: 04/21/2016 02:57 PM] (43) |
| Apr 21, 2016 | 57 | Entry of appearance for Robert A. Armitage as principal counsel for Congressman Lamar Smith. Service: 04/21/2016 by email, US mail. [328619] [Robert Armitage] [Entered: 04/21/2016 04:29 PM] (2) |
| Apr 21, 2016 | 58 | Entry of appearance for Robert A. Armitage as principal counsel for Congressman Lamar Smith. Service: 04/21/2016 by email, US mail. [328624] [Robert Armitage] [Entered: 04/21/2016 04:39 PM] (0) |
| Apr 21, 2016 | 59 | AMICUS BRIEF FILED for Lamar Smith [56]. Number of Pages: 34. Service: 04/21/2016 by email. Pursuant to Fed. Cir. R. 29(a), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 04/27/2016. [328738] [JCA] [Entered: 04/22/2016 10:08 AM] (43) |
| Apr 18, 2016 | 55 | Entry of appearance for Anand B. Patel as of counsel for Appellee Helsinn Healthcare S.A.. Service: 04/18/2016 by email. [327327] [Anand Patel] [Entered: 04/18/2016 06:49 PM] (2) |
| Apr 6, 2016 | 53 | ORDER consolidating appeals (16-1284, 16-1787). Service as of this date by Clerk of Court. [324409] [16-1284, 16-1787] [JCA] [Entered: 04/06/2016 11:38 AM] (2) |
| Apr 6, 2016 | 54 | Note to file: The following cases are associated:16-1284 Lead with 16-1787 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [324418] [16-1284, 16-1787] [JCA] [Entered: 04/06/2016 11:41 AM] (0) |
| Mar 22, 2016 | 52 | ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [50] filed by Appellees Roche Palo Alto LLC, Helsinn Healthcare S.A. and Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. Appellees’ brief is due 04/25/2016 and Appellants’reply brief is due 5/13/16. Service: 03/22/2016 by clerk. [320750] [NL] [Entered: 03/22/2016 12:22 PM] (2) |
| Mar 21, 2016 | 50 | MOTION of Appellants Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Appellees Helsinn Healthcare S.A. and Roche Palo Alto LLC to extend the time to 04/25/2016 to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 04/04/2016, to extend the time to 05/13/2016 to file the reply brief. Response/Opposition is due 04/04/2016 [Consent: unopposed]. Service: 03/21/2016 by email. [320476] [Joseph O'Malley] [Entered: 03/21/2016 03:52 PM] (10) |
| Mar 17, 2016 | 51 | 6 paper copies of the amicus Brief [43] received from Amicus Curiae 42 Intellectual Property Professors. [320625] [LAJ] [Entered: 03/22/2016 09:11 AM] (0) |
| Mar 16, 2016 | 48 | Certificate of Interest for the Amicus Curiae 42 Intellectual Property Professors. Service: 03/16/2016 by email. [319071] [Mark Lemley] [Entered: 03/16/2016 10:34 AM] (7) |
| Mar 15, 2016 | 45 | Entry of appearance for Ron D. Katznelson, Ph.D. as pro se for Amicus Curiae Ron D. Katznelson, Ph.D. Service: 03/15/2016 by clerk. [318909] [JCA] [Entered: 03/15/2016 04:07 PM] (2) |
| Mar 15, 2016 | 46 | TENDERED from Amicus Curiae Ron D. Katznelson, Ph.D.. Title: AMICUS CURIAE BRIEF. [318910] [JCA] [Entered: 03/15/2016 04:09 PM] (37) |
| Mar 15, 2016 | 47 | AMICUS BRIEF FILED for Ron D. Katznelson, Ph.D. [46]. Number of Pages: 27. Service: 03/15/2016 by clerk. [318912] [JCA] [Entered: 03/15/2016 04:11 PM] (37) |
| Mar 15, 2016 | 49 | 6 paper copies of the amicus Brief [47] received from Amicus Curiae Ron D. Katznelson, Ph.D.. [319179] [LAJ] [Entered: 03/16/2016 02:10 PM] (0) |
| Mar 14, 2016 | 40 | Entry of appearance for Robert P Merges as of counsel for 42 Intellectual Property Professors. Service: 03/14/2016 by email. [318507] [Mark Lemley] [Entered: 03/14/2016 07:17 PM] (4) |
| Mar 14, 2016 | 41 | Entry of appearance for Mark A. Lemley as principal counsel for 42 Intellectual Property Professors. Service: 03/14/2016 by email. [318508] [Mark Lemley] [Entered: 03/14/2016 07:19 PM] (3) |
| Mar 14, 2016 | 42 | TENDERED from 42 Intellectual Property Professors Title: AMICUS CURIAE BRIEF. Service: 03/14/2016 by email. [318509] [Mark Lemley] [Entered: 03/14/2016 07:21 PM] (42) |
| Mar 14, 2016 | 43 | AMICUS BRIEF FILED for 42 Intellectual Property Professors [42]. Number of Pages: 22. Service: 03/14/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/21/2016. [318603] [JCA] [Entered: 03/15/2016 09:34 AM] (42) |
| Mar 11, 2016 | 44 | 6 paper copies of the Opening Brief [39] received from Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. [318816] [LAJ] [Entered: 03/15/2016 02:49 PM] (0) |
| Mar 8, 2016 | 37 | NOTICE OF REJECTION: The brief of Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc., Brief for Defendants-Appellants [36], is not in compliance with the rules of this court and is therefore rejected for filing. Brief due 03/22/2016. Appellees Helsinn Healthcare S.A. and Roche Palo Alto LLC brief is due 04/21/2016. Service as of this date by Clerk of Court. [316584] [JCA] [Entered: 03/08/2016 10:00 AM] (2) |
| Mar 8, 2016 | 38 | TENDERED from Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Title: CORRECTED OPENING BRIEF. Service: 03/08/2016 by email. [316775] [Steffen Johnson] [Entered: 03/08/2016 02:41 PM] (290) |
| Mar 8, 2016 | 39 | CORRECTED BRIEF FILED for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. [38]. Number of Pages: 62. Service: 03/08/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/14/2016. Appellees Helsinn Healthcare S.A. and Roche Palo Alto LLC brief is due 04/21/2016. [316820] [JCA] [Entered: 03/08/2016 03:50 PM] (290) |
| Mar 7, 2016 | 36 | TENDERED from Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Title: OPENING BRIEF. Service: 03/07/2016 by email. [316504]. This brief has been rejected. See Doc No.[37] [Steffen Johnson] [Entered: 03/07/2016 06:54 PM] (0) |
| Jan 29, 2016 | 35 | ORDER granting motion to extend time to file appellant/petitioner principal brief [33] filed by Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. Appellants’ brief is due 03/07/2016. Service: 01/29/2016 by clerk. [307146] [NL] [Entered: 01/29/2016 03:20 PM] (2) |
| Jan 27, 2016 | 31 | MOTION of Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. to extend time until 03/07/2016 at 11:59 pm to file (Time to file Opening Brief). Response/Opposition is due 02/08/2016 [Consent: opposed]. Service: 01/26/2016 by email. [305775] [Steffen Johnson] [Entered: 01/26/2016 11:39 PM] (8) |
| Jan 27, 2016 | 32 | Notice of Rejection to Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc., the following document(s): motion to extend time to file (other) [31] is REJECTED for filing. Reason(s): Incorrect relief selected. Service: 01/27/2016 by email. [305974] [JCA] [Entered: 01/27/2016 12:10 PM] (2) |
| Jan 27, 2016 | 33 | MOTION of Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. to extend the time to 03/07/2016 at 11:59 pm to file the appellant/petitioner's principal brief. Response/Opposition is due 02/11/2016 [Consent: opposed]. Service: 01/27/2016 by email. [306146] [Steffen Johnson] [Entered: 01/27/2016 03:03 PM] (8) |
| Jan 27, 2016 | 34 | RESPONSE of Appellees Helsinn Healthcare S.A. and Roche Palo Alto LLC to the motion to extend time to file appellant/petitioner principal brief [33] filed by Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. in 16-1284. Service: 01/27/2016 by email. [306389] [Joseph O'Malley] [Entered: 01/27/2016 06:53 PM] (15) |
| Jan 19, 2016 | 26 | Certificate of Interest for the Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 01/19/2016 by email. [303851] [George Lombardi] [Entered: 01/19/2016 11:17 AM] (0) |
| Jan 19, 2016 | 27 | NOTICE OF DEFICIENCY: The certificate of interest Document No. [26] filed by Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. in 16-1284 is submitted using the incorrect event and therefore cannot be accepted for filing at this time. The document was filed as a Certificate of Interest; however the filing references compliance with Federal Circuit Rule 11(d). You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [303963] [JCA] [Entered: 01/19/2016 12:28 PM] (0) |
| Jan 19, 2016 | 28 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 01/19/2016 by email. [303986] [George Lombardi] [Entered: 01/19/2016 01:05 PM] (4) |
| Jan 19, 2016 | 29 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Roche Palo Alto LLC. Service: 01/19/2016 by email. [304080] [Eric Dittmann] [Entered: 01/19/2016 02:12 PM] (3) |
| Jan 19, 2016 | 30 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Helsinn Healthcare S.A.. Service: 01/19/2016 by email. [304081] [Eric Dittmann] [Entered: 01/19/2016 02:13 PM] (3) |
| Dec 23, 2015 | 25 | Entry of appearance for Karl A. Leonard as of counsel for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/23/2015 by email. [298681] [Karl Leonard] [Entered: 12/23/2015 06:02 PM] (2) |
| Dec 18, 2015 | 2 | Entry of appearance for Joseph M. O'Malley, Jr. as principal counsel for Appellee Helsinn Healthcare S.A.. Service: 12/18/2015 by email. [297496] [Joseph O'Malley] [Entered: 12/18/2015 01:47 PM] (3) |
| Dec 18, 2015 | 3 | Certificate of Interest for the Appellee Helsinn Healthcare S.A.. Service: 12/18/2015 by email. [297497] [Joseph O'Malley] [Entered: 12/18/2015 01:48 PM] (4) |
| Dec 18, 2015 | 4 | Docketing Statement for the Appellee Helsinn Healthcare S.A.. Service: 12/18/2015 by email. [297498] [Joseph O'Malley] [Entered: 12/18/2015 01:49 PM] (5) |
| Dec 18, 2015 | 5 | Entry of appearance for Mark E. Waddell as principal counsel for Appellee Roche Palo Alto LLC. Service: 12/18/2015 by email. [297508] [Mark Waddell] [Entered: 12/18/2015 02:00 PM] (3) |
| Dec 18, 2015 | 6 | Certificate of Interest for the Appellee Roche Palo Alto LLC. Service: 12/18/2015 by email. [297509] [Mark Waddell] [Entered: 12/18/2015 02:01 PM] (4) |
| Dec 18, 2015 | 7 | Docketing Statement for the Appellee Roche Palo Alto LLC. Service: 12/18/2015 by email. [297510] [Mark Waddell] [Entered: 12/18/2015 02:02 PM] (5) |
| Dec 18, 2015 | 8 | Entry of appearance for Stephen B. Kinnaird as of counsel for Appellee Helsinn Healthcare S.A.. Service: 12/18/2015 by email. [297511] [Stephen Kinnaird] [Entered: 12/18/2015 02:05 PM] (3) |
| Dec 18, 2015 | 9 | Entry of appearance for Isaac S. Ashkenazi as of counsel for Appellee Helsinn Healthcare S.A.. Service: 12/18/2015 by email. [297513] [Isaac Ashkenazi] [Entered: 12/18/2015 02:14 PM] (3) |
| Dec 18, 2015 | 10 | Entry of appearance for Charles M. Lizza as of counsel for Appellee Helsinn Healthcare S.A.. Service: 12/18/2015 by email. [297515] [Charles Lizza] [Entered: 12/18/2015 02:18 PM] (0) |
| Dec 18, 2015 | 11 | Entry of appearance for Young J. Park as of counsel for Appellee Helsinn Healthcare S.A.. Service: 12/18/2015 by email. [297517] [Young Park] [Entered: 12/18/2015 02:20 PM] (3) |
| Dec 18, 2015 | 12 | Entry of appearance for Eric W. Dittmann as of counsel for Appellee Helsinn Healthcare S.A.. Service: 12/18/2015 by email. [297519] [Eric Dittmann] [Entered: 12/18/2015 02:23 PM] (3) |
| Dec 18, 2015 | 13 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [10] filed by Appellee Helsinn Healthcare S.A. in 16-1284 is cannot be accepted for filing at this time. The document was filed as "Entry of Appearance for Charles M. Lizza as of counsel for Appellee Helsinn Healthcare S.A.", however the body of the document lists you as of counsel to Helsinn Healthcare S.A., Roche Palo Alto LLC. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [297550] [JCA] [Entered: 12/18/2015 03:02 PM] (0) |
| Dec 18, 2015 | 14 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [11], ERROR: The firm name and contact information on the entry of appearance do match what we have on file. CORRECTION: Please update your firm name and contact information with the PACER service center. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [297555] [JCA] [Entered: 12/18/2015 03:08 PM] (0) |
| Dec 18, 2015 | 15 | Entry of appearance for George C. Lombardi as principal counsel for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2015 by email. [297657] [George Lombardi] [Entered: 12/18/2015 04:28 PM] (2) |
| Dec 18, 2015 | 16 | Docketing Statement for the Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2015 by email. [297659] [George Lombardi] [Entered: 12/18/2015 04:30 PM] (4) |
| Dec 18, 2015 | 17 | Certificate of Interest for the Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2015 by email. [297661] [George Lombardi] [Entered: 12/18/2015 04:32 PM] (2) |
| Dec 18, 2015 | 18 | Transcript Purchase Order Form for the Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. indicating that a transcript is already on file. Service: 12/18/2015 by email. [297664] [George Lombardi] [Entered: 12/18/2015 04:34 PM] (2) |
| Dec 18, 2015 | 19 | Entry of appearance for Tyler G. Johannes as of counsel for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2015 by email. [297668] [Tyler Johannes] [Entered: 12/18/2015 04:39 PM] (2) |
| Dec 18, 2015 | 20 | Entry of appearance for Julia Mano Johnson as of counsel for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2015 by email. [297671] [Julia Johnson] [Entered: 12/18/2015 04:48 PM] (2) |
| Dec 18, 2015 | 21 | Entry of appearance for Steffen N. Johnson as of counsel for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2015 by email. [297676] [Steffen Johnson] [Entered: 12/18/2015 04:51 PM] (2) |
| Dec 18, 2015 | 22 | Entry of appearance for Andrew C. Nichols as of counsel for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2015 by email. [297683] [Andrew Nichols] [Entered: 12/18/2015 04:56 PM] (2) |
| Dec 18, 2015 | 23 | Entry of appearance for Jovial Wong as of counsel for Appellants Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2015 by email. [297685] [Jovial Wong] [Entered: 12/18/2015 04:59 PM] (2) |
| Dec 18, 2015 | 24 | Entry of appearance for Charles M. Lizza as of counsel for Appellees Helsinn Healthcare S.A. and Roche Palo Alto LLC. Service: 12/18/2015 by email. [297701] [Charles Lizza] [Entered: 12/18/2015 05:34 PM] (3) |
| Dec 4, 2015 | 1 | Appeal docketed. Received: 12/03/2015. [293675]Entry of Appearance due 12/18/2015. Certificate of Interest is due on 12/18/2015. Docketing Statement due 12/18/2015. Appellant/Petitioner's brief is due 02/02/2016. [JCA] [Entered: 12/04/2015 01:12 PM] (66) |
